US biotech Voyager Therapeutics saw its shares close down 21% at $4.20 on Tuesday, after it revealed its decision to assess ...

Medicare Advantage plans are health insurance alternatives to Original Medicare, which provides health insurance to people ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2024 financial ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Jacquelyn Fahey Sandell, Chief Legal Officer at Voyager Therapeutics, Inc. (NASDAQ:VYGR), recently sold shares of the company, according to a filing with the Securities and Exchange Commission. The ...

In a recent transaction, Alfred Sandrock, President and CEO of Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotech company with a market capitalization of $240 million and strong financial health ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...

Less than a month after researchers unveiled that a “ticking DNA clock” is behind Huntington’s disease (HD), scientists have ...

YouTube is flooded now with videos made using artificial intelligence.There are music videos of world leaders singing or ...

Josh Allen beat out two-time winner Lamar Jackson for the Most Valuable Player award in the closest race since Matt Ryan beat ...

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...